Showing results (1-10 of 55) with videos related to
Sort By:
Pageof 6
Radiation Oncology (London, England)|May 4, 2017
Sparing of normal tissues with volumetric arc radiation therapy for glioblastoma: single institution clinical experienceTina Marie Briere, Mary Frances McAleer, Lawrence B Levy, et al.International Journal of Radiation Oncology, Biology, Physics|July 23, 2003
Use of portal images and BAT ultrasonography to measure setup error and organ motion for prostate IMRT: implications for treatment marginsDarren J Little, Lei Dong, Lawrence B Levy, et al.American Journal of Clinical Oncology|December 15, 2010
Toxicity associated with postoperative radiation therapy for prostate cancerPuneeth Iyengar, Lawrence B Levy, Seungtaek Choi, et al.Urology|October 11, 2003
Quality-of-life questionnaire results 2 and 3 years after radiotherapy for prostate cancer in a randomized dose-escalation studyDarren J Little, Deborah A Kuban, Lawrence B Levy, et al.Cancer|February 28, 2009
Late rectal complications after prostate brachytherapy for localized prostate cancer: incidence and managementJack Phan, David A Swanson, Lawrence B Levy, et al.International Journal of Radiation Oncology, Biology, Physics|May 10, 2003
Incomplete glandular ablation after salvage cryotherapy for recurrent prostate cancer after radiotherapyJonathan I Izawa, Nora Morganstern, Deva M Chan, et al.The Journal of Urology|July 20, 2002
Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with external beam radiationCharles J Rosser, Ramsay Chichakli, Lawrence B Levy, et al.The Journal of Urology|June 17, 2014
Current clinical presentation and treatment of localized prostate cancer in the United StatesUsama Mahmood, Lawrence B Levy, Paul L Nguyen, et al.International Journal of Radiation Oncology, Biology, Physics|May 25, 2010
Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?Deborah A Kuban, Lawrence B Levy, M Rex Cheung, et al.The Journal of Urology|May 29, 2003
Hazard rates of disease progression after external beam radiotherapy for clinically localized carcinoma of the prostateCharles J Rosser, Lawrence B Levy, Deborah A Kuban, et al.Pageof 6